The program’s demonstration run will last from July 1, 2026, until December 31, 2027, Medicare said.
Medicare launches pilot program expanding access to GLP-1 drugs
Welcome to LJ News Opinions, where breaking news stories have captivated us for over 20 years.
Join us in this journey of sharing points of view about the news – read, react, engage, and unleash your opinion!